{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-25-000083","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.241833+00:00","generated_at":"2026-05-17T03:51:53.622643+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"low","headline":"AnaptysBio holds ANB033 (CD122 antagonist) investor event; updates corporate presentation","bullets":["Conference call and slide presentation on ANB033 (CD122 antagonist) held on October 14, 2025.","Updated corporate investor presentation filed as Exhibit 99.2; no specific clinical or financial data disclosed in the filing text.","Event intended to provide pipeline update; details of ANB033 discussion not expanded in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-25-000083","json":"https://secwatch.observer/filing/0001370053-25-000083.json","markdown":"https://secwatch.observer/filing/0001370053-25-000083.md","text":"https://secwatch.observer/filing/0001370053-25-000083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005325000083/0001370053-25-000083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005325000083/anab-20251014.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:51:53.622643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}